Literature DB >> 20785660

Influence of Synthetic Oestrogens on Advanced Malignant Disease.

A Haddow, J M Watkinson, E Paterson, P C Koller.   

Abstract

Entities:  

Year:  1944        PMID： 20785660      PMCID： PMC2286289          DOI： 10.1136/bmj.2.4368.393

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  66 in total

1.  Plasma Acid Phosphatase in Carcinoma of Prostate: Effect of Stilboestrol.

Authors:  J M Watkinson; G E Delory; E J King; A Haddow
Journal:  Br Med J       Date:  1944-10-14

2.  Endocrine Treatment - 'Old-Fashioned' Therapy Becoming Redundant in an Era of Molecular Medicine?

Authors:  Per Eystein Lønning
Journal:  Breast Care (Basel)       Date:  2008-12-02       Impact factor: 2.860

3.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

4.  Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.

Authors:  Chrisandra Shufelt; C Noel Bairey Merz; Mary B Pettinger; Lydia Choi; Rowan Chlebowski; Carolyn J Crandall; Simin Liu; Dorothy Lane; Ross Prentice; JoAnn E Manson
Journal:  Menopause       Date:  2018-09       Impact factor: 2.953

5.  Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer.

Authors:  Joan S Lewis-Wambi; Ramona Swaby; Helen Kim; V Craig Jordan
Journal:  J Steroid Biochem Mol Biol       Date:  2009-01-09       Impact factor: 4.292

6.  The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Authors:  V Craig Jordan; Ifeyinwa Obiorah; Ping Fan; Helen R Kim; Eric Ariazi; Heather Cunliffe; Hiltrud Brauch
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

7.  Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Authors:  Eric A Ariazi; Heather E Cunliffe; Joan S Lewis-Wambi; Michael J Slifker; Amanda L Willis; Pilar Ramos; Coya Tapia; Helen R Kim; Smitha Yerrum; Catherine G N Sharma; Emmanuelle Nicolas; Yoganand Balagurunathan; Eric A Ross; V Craig Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

8.  Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol.

Authors:  I E Obiorah; V C Jordan
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

9.  Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.

Authors:  Ping Fan; V Craig Jordan
Journal:  Steroids       Date:  2014-06-12       Impact factor: 2.668

10.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.